AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.59) per share. This is a 82.39 percent increase over losses of $(3.35) per share from the same period last year.
A Look Into Illumina’s Debt
Shares of Illumina Inc. (NASDAQ:ILMN) rose by 4.16% in the past three months. When understanding a companies price…
